BMP2 and focal segmental glomerulosclerosis: Our results indicated that the YSHS granule may be an effective drug to alleviate glomerular fibrosis in FSGS and BMP2 may be served as an effective therapeutic target in the treatment of renal fibrosis and FSGS.